Gabelli Funds’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.28M Sell
31,017
-2,244
-7% -$608K 0.06% 372
2025
Q4
$8.34M Sell
33,261
-8,000
-19% -$2.12M 0.06% 357
2025
Q3
$11.8M Sell
41,261
-2,842
-6% -$761K 0.08% 292
2025
Q2
$11.6M Sell
44,103
-5,582
-11% -$1.36M 0.08% 290
2025
Q1
$11.6M Hold
49,685
0.09% 282
2024
Q4
$11.4M Sell
49,685
-900
-2% -$206K 0.09% 279
2024
Q3
$11.3M Sell
50,585
-300
-0.6% -$65.9K 0.08% 292
2024
Q2
$10.4M Sell
50,885
-235
-0.5% -$47.8K 0.08% 302
2024
Q1
$11.2M Sell
51,120
-615
-1% -$135K 0.08% 291
2023
Q4
$11.8M Sell
51,735
-2,375
-4% -$499K 0.09% 276
2023
Q3
$10.9M Sell
54,110
-8,990
-14% -$1.9M 0.09% 289
2023
Q2
$13.1M Sell
63,100
-41
-0.1% -$7.95K 0.1% 261
2023
Q1
$12.4M Sell
63,141
-29
-0% -$5.97K 0.09% 272
2022
Q4
$12.8M Buy
63,170
+233
+0.4% +$45.5K 0.1% 269
2022
Q3
$11.1M Buy
62,937
+23
+0% +$4.71K 0.09% 283
2022
Q2
$12.7M Buy
62,914
+169
+0.3% +$36K 0.1% 282
2022
Q1
$14.2M Buy
62,745
+459
+0.7% +$108K 0.09% 283
2021
Q4
$16.8M Buy
62,286
+844
+1% +$209K 0.11% 241
2021
Q3
$14.9M Buy
61,442
+349
+0.6% +$88K 0.1% 256
2021
Q2
$14.5M Sell
61,093
-1,647
-3% -$375K 0.09% 275
2021
Q1
$13.7M Sell
62,740
-2,910
-4% -$584K 0.09% 283
2020
Q4
$11.5M Buy
65,650
+815
+1% +$141K 0.08% 305
2020
Q3
$10.5M Sell
64,835
-5,820
-8% -$922K 0.08% 303
2020
Q2
$10.1M Hold
70,655
0.08% 303
2020
Q1
$7.67M Sell
70,655
-5,820
-8% -$839K 0.07% 335
2019
Q4
$11.1M Hold
76,475
0.07% 321
2019
Q3
$11M Hold
76,475
0.07% 317
2019
Q2
$11.4M Hold
76,475
0.07% 325
2019
Q1
$10.1M Buy
76,475
+5,820
+8% +$717K 0.06% 362
2018
Q4
$7.67M Hold
70,655
0.05% 394
2018
Q3
$10.5M Buy
70,655
+2,445
+4% +$372K 0.06% 376
2018
Q2
$10.5M Sell
68,210
-1,863
-3% -$281K 0.06% 378
2018
Q1
$9.74M Sell
70,073
-2,328
-3% -$342K 0.06% 384
2017
Q4
$9.92M Buy
72,401
+15,132
+26% +$2M 0.06% 390
2017
Q3
$7.43M Buy
57,269
+2,328
+4% +$311K 0.04% 463
2017
Q2
$7.28M Hold
54,941
0.04% 462
2017
Q1
$6.77M Buy
54,941
+1,164
+2% +$138K 0.04% 478
2016
Q4
$5.93M Hold
53,777
0.04% 503
2016
Q3
$6.35M Sell
53,777
-41,089
-43% -$4.84M 0.04% 479
2016
Q2
$10.6M Sell
94,866
-9,312
-9% -$1M 0.06% 366
2016
Q1
$10.5M Buy
104,178
+12,804
+14% +$1.23M 0.06% 367
2015
Q4
$9.71M Buy
91,374
+11,640
+15% +$1.2M 0.06% 396
2015
Q3
$7.43M Buy
79,734
+4,656
+6% +$482K 0.04% 457
2015
Q2
$7.82M Buy
75,078
+7,480
+11% +$779K 0.04% 474
2015
Q1
$7.32M Buy
67,598
+8,234
+14% +$847K 0.04% 504
2014
Q4
$5.5M Hold
59,364
0.03% 572
2014
Q3
$5.19M Hold
59,364
0.03% 581
2014
Q2
$5.22M Hold
59,364
0.03% 586
2014
Q1
$5.01M Buy
59,364
+582
+1% +$46.4K 0.03% 575
2013
Q4
$4.61M Hold
58,782
0.02% 583
2013
Q3
$5.01M Hold
58,782
0.03% 559
2013
Q2
$5.05M Buy
+58,782
New +$4.88M 0.03% 528

Other funds holding LH

Gabelli Funds's LH Position: Q1 2026 in Review

Gabelli Funds reduced its Labcorp (LH) stake by 6.7% in Q1 2026, selling an estimated $608K and leaving 31,017 shares worth $8.28M. The position accounts for 0.06% of the portfolio, ranked #372.

Gabelli Funds first reported a position in LH in Q2 2013 and has held it in 52 quarters since. The position peaked at $16.8M in Q4 2021. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Gabelli Funds held 31,017 shares of Labcorp worth $8.28M as of Q1 2026.
  • Gabelli Funds sold 2,244 Labcorp shares in Q1 2026, an estimated $608K.
  • Labcorp made up 0.06% of Gabelli Funds's portfolio in Q1 2026, its #372 holding.
  • Gabelli Funds first reported a position in Labcorp in Q2 2013 and has held it in 52 quarters since.
  • Gabelli Funds's Labcorp position peaked at $16.8M in Q4 2021.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Gabelli Funds's 13F filing for Q1 2026, filed 14 May 2026.